BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23006927)

  • 21. Susceptibility of TLR4-defective C3H/HeJ mice to Coccidioides posadasii infection.
    Awasthi S
    Med Mycol; 2010 May; 48(3):470-5. PubMed ID: 20370361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Th1-type immune response to a Coccidioides immitis antigen delivered by an attenuated strain of the non-invasive enteropathogen Vibrio cholerae.
    Silva AJ; Benitez JA
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):393-8. PubMed ID: 15708313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
    Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
    Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
    Xue J; Hung CY; Yu JJ; Cole GT
    Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1.
    Viriyakosol S; Fierer J; Brown GD; Kirkland TN
    Infect Immun; 2005 Mar; 73(3):1553-60. PubMed ID: 15731053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of phagocyte NADPH oxidase 2 leads to severe inflammatory response in lungs of mice infected with Coccidioides.
    Gonzalez A; Hung CY; Cole GT
    Microb Pathog; 2011 Dec; 51(6):432-41. PubMed ID: 21896326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-8 Receptor 2 (IL-8R2)-Deficient Mice Are More Resistant to Pulmonary Coccidioidomycosis than Control Mice.
    Carlin AF; Viriyakosol S; Okamoto S; Walls L; Fierer J
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33106296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic evidence for the role of the Lv locus in early susceptibility but not IL-10 synthesis in experimental coccidioidomycosis in C57BL mice.
    Fierer J; Walls L; Kirkland TN
    J Infect Dis; 2000 Feb; 181(2):681-5. PubMed ID: 10669355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
    Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
    Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis.
    Wiederhold NP; Shubitz LF; Najvar LK; Jaramillo R; Olivo M; Catano G; Trinh HT; Yates CM; Schotzinger RJ; Garvey EP; Patterson TF
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
    Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT
    Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cell-based immunization induces Coccidioides Ag2/PRA-specific immune response.
    Awasthi S; Vilekar P; Conkleton A; Rahman N
    Vaccine; 2019 Mar; 37(12):1685-1691. PubMed ID: 30795939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Coccidioides posadasii CPS1 Deletion Mutant Is Avirulent and Protects Mice from Lethal Infection.
    Narra HP; Shubitz LF; Mandel MA; Trinh HT; Griffin K; Buntzman AS; Frelinger JA; Galgiani JN; Orbach MJ
    Infect Immun; 2016 Oct; 84(10):3007-16. PubMed ID: 27481239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coccidioidomycosis: host response and vaccine development.
    Cox RA; Magee DM
    Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of Specific Peptides for
    Duarte Escalante E; Frías De León MG; Martínez García LG; Herrera J; Acosta Altamirano G; Cabello C; Palma G; Reyes Montes MDR
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30513599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.
    Li K; Yu JJ; Hung CY; Lehmann PF; Cole GT
    Infect Immun; 2001 May; 69(5):2878-87. PubMed ID: 11292702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of reactive oxygen intermediates in experimental coccidioidomycois in mice.
    Margolis DA; Viriyakosol S; Fierer J; Kirkland TN
    BMC Microbiol; 2011 Apr; 11():71. PubMed ID: 21481258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathology of coccidioidomycosis in llamas and alpacas.
    Fernandez JA; Hidalgo MN; Hodzic E; Diab SS; Uzal FA
    J Vet Diagn Invest; 2018 Jul; 30(4):560-564. PubMed ID: 29790449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
    Jiang C; Magee DM; Ivey FD; Cox RA
    Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of IL-10 in genetic susceptibility to coccidioidomycosis on mice.
    Fierer J
    Ann N Y Acad Sci; 2007 Sep; 1111():236-44. PubMed ID: 17363443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.